Another early study in breast cancer revealed that NAA10 directly interacts with tuberous sclerosis complex 2 (TSC2) and mediates its N-terminal acetylation, resulting in TSC2 stabilization, suppression of mTOR signaling, and induction of autophagy [88]. This evidence concerns the gene NAA10 and breast cancer.